Lambert Busque
0000-0002-5375-3749
Publication & Citation Trends
Publications
0 total
Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders
Cited by 0
Semantic Scholar
Cryptic leukemia antigens share homology with microbial epitopes and stimulate T-cell responses in healthy donors
Cited by 0
Semantic Scholar
Enhancing CAR-T Efficacy in Large B-Cell Lymphoma with Radiation Bridging Therapy: A Real-World Single-Center Experience OA
Cited by 4
Semantic Scholar
Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study
Cited by 0
Semantic Scholar
CALR mutation burden in essential thrombocythemia and disease outcome. OA
Cited by 12
Semantic Scholar
Combined PD-L1 and TIM3 blockade improves expansion of fit human CD8+ antigen-specific T cells for adoptive immunotherapy OA
Cited by 10
Semantic Scholar
Persistence with Generic Imatinib for Chronic Myeloid Leukemia: A Matched Cohort Study
Cited by 0
Semantic Scholar
Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients OA
Cited by 14
Semantic Scholar
Research Topics
Cardiovascular Health and Risk Factors
(94)
Chemotherapy-induced cardiotoxicity and mitigation
(91)
Acute Myeloid Leukemia Research
(61)
Chronic Myeloid Leukemia Treatments
(61)
Myeloproliferative Neoplasms: Diagnosis and Treatment
(49)
Affiliations
Brigham and Women's Hospital
Howard Hughes Medical Institute
Harvard University
Bell (Canada)
Louisiana-Pacific (Canada)